Conflict of interest statement: The author is on Roche Advisory board forbiomarker testing in India and member of the SPHERE programme.111. Proc Natl Acad Sci U S A. 2018 Feb 27;115(9):E1940. doi: 10.1073/pnas.1721225115.Epub 2018 Feb 6.Radiation oncology authors and reviewers prefer double-blind peer review.Bennett KE(1), Jagsi R(2), Zietman A(3).Author information: (1)American Society for Radiation Oncology, Arlington, VA 22202;katherine.bennett@astro.org.(2)Department of Radiation Oncology, University of Michigan, Ann Arbor, MI 48109.(3)Department of Radiation Oncology, Massachusetts General Hospital, Boston, MA02114.Comment in    Proc Natl Acad Sci U S A. 2018 Feb 27;115(9):E1941.Comment on    Proc Natl Acad Sci U S A. 2017 Nov 28;114(48):12708-12713.DOI: 10.1073/pnas.1721225115 PMCID: PMC5834726 [Available on 2018-08-27]PMID: 29434045  [Indexed for MEDLINE]